Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells. (Q53493928)

14 May 2018

title

Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells. (English)

1 reference

14 May 2018

1 reference

Kristian M Hargadon

1

1 reference

14 May 2018

Johnathan D Bishop

2

1 reference

14 May 2018

John P Brandt

3

1 reference

14 May 2018

Zachary C Hand

4

1 reference

14 May 2018

Yonathan T Ararso

5

1 reference

14 May 2018

Osric A Forrest

6

1 reference

14 May 2018

publication date

26 May 2015

1 reference

14 May 2018

Immunology & Cell Biology

published in

1 reference

14 May 2018

volume

94

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

page(s)

24-38

1 reference

14 May 2018

Dendritic cells and the control of immunity

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Innate immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Activation of dendritic cells: translating innate into adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Immune surveillance against a solid tumor fails because of immunological ignorance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Tumor-altered dendritic cell function: implications for anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Suppression of the maturation and activation of the dendritic cell line DC2.4 by melanoma-derived factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Induction of myeloid-derived suppressor cells by tumor exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Limitations with in vitro production of dendritic cells using cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Ovarian cancer progression is controlled by phenotypic changes in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Strategies and challenges in eliciting immunity to melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Identification of interferon-beta-stimulated genes that inhibit angiogenesis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Differential response of respiratory dendritic cell subsets to influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2015.58

Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow

21 January 2018

1 reference

12 December 2020

Immunologic evaluation of spontaneous regression of an intraocular murine melanoma.

1 reference

12 December 2020

Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy

1 reference

12 December 2020

Validation of bone marrow derived dendritic cells as an appropriate model to study tumor-mediated suppression of DC maturation through STAT3 hyperactivation.

1 reference

12 December 2020

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

12 December 2020

IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages

1 reference

12 December 2020

Significance of M2-polarized tumor-associated macrophage in pancreatic cancer

1 reference

12 December 2020

Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.

1 reference

12 December 2020

Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer.

1 reference

12 December 2020

The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma

1 reference

12 December 2020

Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors

1 reference

12 December 2020

Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.

1 reference

12 December 2020

Role of CXCL1 in tumorigenesis of melanoma.

1 reference

12 December 2020

Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma

1 reference

12 December 2020

Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo

1 reference

12 December 2020

Identifiers

DOI

10.1038/ICB.2015.58

1 reference

14 May 2018

1 reference

14 May 2018